Lidow M S, Goldman-Rakic P S, Gallager D W, Rakic P
Yale University, School of Medicine, Section of Neuroanatomy, New Haven, CT 06510.
Neuroscience. 1991;40(3):657-71. doi: 10.1016/0306-4522(91)90003-7.
A widespread distribution of dopamine D1 receptors in the neocortex is well recognized. However, the presence of dopamine D2 receptors in this structure has only recently been established [Martres et al. (1985) Eur. J. Pharmac. 118, 211-219; Lidow et al. (1989) Proc. natn. Acad. Sci. U.S.A. 86, 6412-6416]. In the present paper, a highly specific antagonist, [3H]raclopride, was used for autoradiographic determination of the distribution of D2 receptors in 12 cytoarchitectonic areas of the frontal, parietal, and occipital lobes of the rhesus monkey. A low density of D2-specific [3H]raclopride binding (1.5-4.0 fmol/mg tissue) was detected in all layers of all cortical areas studied. Throughout the entire cortex, the highest density of binding was consistently found in layer V. This is a unique distribution not observed so far for any other neurotransmitter receptor subtype in monkey cerebral cortex, including D1 receptor. In addition, a comparison was made of the distribution of [3H]raclopride and [3H]spiperone, which has been commonly used in previous attempts to label cortical D2 receptors. We found marked differences in the distribution of these two radioligands. In the prefrontal cortex, the pattern of [3H]spiperone binding in the presence of ketanserin resembled the combined distribution of 5-HT1C serotoninergic and alpha 2-adrenergic sites as well as D2 receptors. Thus, [3H]raclopride provides a better estimation of the D2 receptor distribution than does [3H]spiperone. The distribution of D2-specific binding of [3H]raclopride was also compared with the D1-specific binding of [3H]SCH23390 in the presence of mianserin to block labeling to 5-HT2 and 5-HT1C sites. The density of D1-specific [3H]SCH23390 binding was 10-20 times higher than that of D2-specific [3H]raclopride binding throughout the cortex. The densities of both [3H]raclopride and [3H]SCH23390 binding sites display a rostral-caudal gradient with the highest concentrations in prefrontal and the lowest concentrations in the occipital cortex. However, the binding sites of these two ligands had different laminar distributions in all areas examined. In contrast to preferential [3H]raclopride binding in layer V, a bilaminar pattern of [3H]SCH23390 labeling was observed in most cytoarchitectonic areas, with the highest concentrations in supragranular layers I, II and IIIa and infragranular layers V and VI. Whereas [3H]raclopride binding was similar in all cytoarchitectonic areas, [3H]SCH23390 exhibited some region-specific variations in the primary visual and motor cortex. The different regional and laminar distributions of D1 and D2 dopaminergic receptors indicates that they may subserve different aspects of dopamine function in the cerebral cortex.
多巴胺D1受体在新皮层中的广泛分布已得到充分认识。然而,该结构中多巴胺D2受体的存在直到最近才得以确定[马特雷斯等人(1985年),《欧洲药理学杂志》118卷,211 - 219页;利多等人(1989年),《美国国家科学院院刊》86卷,6412 - 6416页]。在本文中,一种高度特异性的拮抗剂[3H]雷氯必利被用于放射自显影法测定恒河猴额叶、顶叶和枕叶12个细胞构筑区中D2受体的分布。在所研究的所有皮质区域的各层中均检测到低密度的D2特异性[3H]雷氯必利结合(1.5 - 4.0飞摩尔/毫克组织)。在整个皮质中,结合密度最高的始终是第V层。这是一种独特的分布,在猴脑皮质中,包括D1受体在内,迄今为止尚未在任何其他神经递质受体亚型中观察到。此外,还对[3H]雷氯必利和[3H]螺哌隆的分布进行了比较,[3H]螺哌隆在先前标记皮质D2受体的尝试中常用。我们发现这两种放射性配体的分布存在显著差异。在额叶前皮质,酮色林存在时[3H]螺哌隆的结合模式类似于5 - HT1C血清素能和α2 - 肾上腺素能位点以及D2受体的联合分布。因此,与[3H]螺哌隆相比,[3H]雷氯必利能更好地估计D2受体的分布。在米安色林存在以阻断对5 - HT2和5 - HT1C位点的标记时,还将[3H]雷氯必利D2特异性结合的分布与[3H]SCH23390的D1特异性结合进行了比较。在整个皮质中,D1特异性[3H]SCH23390结合的密度比D2特异性[3H]雷氯必利结合的密度高10 - 20倍。[3H]雷氯必利和[3H]SCH23390结合位点的密度均呈现从前向后的梯度,额叶前皮质中的浓度最高,枕叶皮质中的浓度最低。然而,在所有检查区域中,这两种配体的结合位点具有不同的层状分布。与[3H]雷氯必利在第V层的优先结合不同,在大多数细胞构筑区观察到[3H]SCH23390标记的双分层模式,在颗粒上层I、II和IIIa以及颗粒下层V和VI中的浓度最高。虽然[3H]雷氯必利在所有细胞构筑区的结合相似,但[3H]SCH23390在初级视觉和运动皮质中表现出一些区域特异性变化。D1和D2多巴胺能受体不同的区域和层状分布表明它们可能在大脑皮质中发挥多巴胺功能的不同方面。